NASDAQ: GDRXGoodrx Holdings Inc Stock
$4.49+0.04 (+0.9%)
Updated Apr 17, 2025
GDRX Price
$4.49
Fair Value Price
$4.56
Market Cap
$1.72B
52 Week Low
$3.82
52 Week High
$9.26
P/E
112.13x
P/B
2.37x
P/S
2.26x
PEG
1.16x
Dividend Yield
N/A
Revenue
$792.32M
Earnings
$16.39M
Gross Margin
93.9%
Operating Margin
10.65%
Profit Margin
2.1%
Debt to Equity
0.92
Operating Cash Flow
$184M
Beta
1.71
Next Earnings
May 7, 2025
Ex-Dividend
N/A
Next Dividend
N/A
GDRX Overview
GoodRx Holdings, Inc. operates a telemedicine platform. It alos offers a website/mobile app that tracks prescription drug prices in the U.S. and provides coupons for discounts on medications. Its telemedicine platform, GoodRx Care, allows individuals to consult with a doctor online and obtain a prescription for certain types of medications as well as obtain referrals for medical testing. GoodRx was founded in 2011 and is headquartered in Santa Monica, CA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine GDRX's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Health Information Service
Industry Rating
B
GDRX
Ranked#7 of 44
Ranked#7 of 44
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $149.00 | A | |
| $62.37 | A | |
| $1.42 | B |
Be the first to know about important GDRX news, forecast changes, insider trades & much more!
GDRX News
Overview
Due Diligence Score
–
Industry Average (25)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how GDRX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
GDRX ($4.49) is undervalued by 1.63% relative to our estimate of its Fair Value price of $4.56 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
GDRX ($4.49) is not significantly undervalued (1.63%) relative to our estimate of its Fair Value price of $4.56 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
GDRX ($4.49) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more GDRX due diligence checks available for Premium users.
Valuation
GDRX fair value
Fair Value of GDRX stock based on Discounted Cash Flow (DCF)
Price
$4.49
Fair Value
$4.56
Undervalued by
1.52%
GDRX ($4.49) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
GDRX ($4.49) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
GDRX ($4.49) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
GDRX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
112.13x
Industry
11.14x
Market
27.98x
GDRX is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
GDRX is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
GDRX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.37x
Industry
3.39x
GDRX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
GDRX price to earnings growth (PEG)
For valuing profitable companies with growth potential
GDRX is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
GDRX's financial health
Profit margin
Revenue
$198.6M
Net Income
$6.7M
Profit Margin
3.4%
GDRX's Earnings (EBIT) of $84.38M... subscribe to Premium to read more.
Interest Coverage Financials
GDRX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.4B
Liabilities
$663.4M
Debt to equity
0.92
GDRX's short-term assets ($659.26M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
GDRX's short-term assets ($659.26M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
GDRX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
GDRX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$44.7M
Investing
-$16.6M
Financing
-$3.5M
GDRX's operating cash flow ($183.89M)... subscribe to Premium to read more.
Debt Coverage Financials
GDRX vs Health Information Service Stocks
Goodrx Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.